Publications by authors named "Michael Rudolf"

Claim this Profile
T
The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.
Thomas Secher, Stefanie Fas, Louis Fauconnier, Marieke Mathieu, Oliver Rutschi, Michael Rudolf

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a 4-valent genotyping assay for direct identification of the most frequent Pseudomonas aeruginosa serotypes from respiratory specimens of pneumonia patients.
Holger Koch, Thomas Emrich, Sandra Jampen, Marianne Wyss, Verena Gafner, Michael P Rudolf

J Med Microbiol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes.
Qin Lu, Philippe Eggimann, Charles-Edouard Luyt, Michel Wolff, Michael Tamm, Michael P Rudolf

Crit Care· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study.
Ronald Dahl, Kenneth R Chapman, Michael Rudolf, Rajendra Mehta, Pearl Kho

Respir Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
Qin Lu, Jean-Jacques Rouby, Pierre-François Laterre, Philippe Eggimann, Anthony Dugard, Michael P Rudolf

J Antimicrob Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's nice about the new NICE guideline?
John O'Reilly, Michael Rudolf

Thorax· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
Michael P Horn, Adrian W Zuercher, Martin A Imboden, Michael P Rudolf, Hedvika Lazar

Antimicrob Agents Chemother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance.
John O'Reilly, Melvyn M Jones, Jill Parnham, Kate Lovibond, Michael Rudolf

BMJ· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative characterization of dipentameric (IgM)(2) and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use.
Markus Tarköy, Marianne Wyss, Michael P Rudolf

J Pharm Biomed Anal· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does rheumatoid arthritis need to be managed?
Chris Deighton, Michael Rudolf

Clin Med (Lond)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of rheumatoid arthritis: summary of NICE guidance.
Chris Deighton, Rachel O'Mahony, Jonathan Tosh, Claire Turner, Michael Rudolf

BMJ· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation: Rate control and digoxin.
Gregory Y H Lip, Michael Rudolf,

BMJ· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD and death: what exactly is the relationship?
Michael Rudolf

Thorax· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of atrial fibrillation: the NICE guidelines.
Gregory Y H Lip, Michael Rudolf, Puneet Kakar

Int J Clin Pract· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focusing on COPD.
Michael Rudolf

Prof Nurse· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD: The role of primary care in effective diagnosis, treatment and management.
Onno Cp van Schayck, Klaus F Rabe, Michael Rudolf

Prim Care Respir J· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.
Sanne Weijzen, Paola Rizzo, Mike Braid, Radhika Vaishnav, Suzanne M Jonkheer, Michael Rudolf

Nat Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.
Steven C Fausch, Diane M Da Silva, Michael P Rudolf, W Martin Kast

J Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis